Cargando…
Review of Autism Profiles and Response to Sertraline in Fragile X Syndrome-Associated Autism vs. Non-syndromic Autism; Next Steps for Targeted Treatment
Given significant genetic, molecular, and phenotypic overlaps, researchers have begun to investigate whether targeted treatments for Fragile X Syndrome (FXS) could also be beneficial for patients with Autism Spectrum Disorder (ASD). For example, low-dose sertraline, an SSRI, was used in two recent c...
Autores principales: | Rajaratnam, Akash, Potter, Laura Axelrod, Biag, Hazel Maridith Barlahan, Schneider, Andrea, Petrasic, Ignacio Cortina, Hagerman, Randi Jenssen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661746/ https://www.ncbi.nlm.nih.gov/pubmed/33193037 http://dx.doi.org/10.3389/fneur.2020.581429 |
Ejemplares similares
-
A Randomized Controlled Trial of Sertraline in Young Children With Autism Spectrum Disorder
por: Potter, Laura A., et al.
Publicado: (2019) -
Metformin treatment in young children with fragile X syndrome
por: Biag, Hazel Maridith B., et al.
Publicado: (2019) -
Intercorrelation of Molecular Biomarkers and Clinical Phenotype Measures in Fragile X Syndrome
por: Aishworiya, Ramkumar, et al.
Publicado: (2023) -
Fragile X and autism: Intertwined at the molecular level leading to targeted treatments
por: Hagerman, Randi, et al.
Publicado: (2010) -
EEG Signal Complexity Is Reduced During Resting-State in Fragile X Syndrome
por: Proteau-Lemieux, Mélodie, et al.
Publicado: (2021)